Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Hemorrhage 13Neoplasms 7Leiomyoma 6Breast Neoplasms 6Hematologic Neoplasms 4Thrombocytopenia 3Postoperative Hemorrhage 3Meningioma 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Seroma 2Prostatic Neoplasms 2Ovarian Neoplasms 2Myofibroma 2Head and Neck Neoplasms 2Colonic Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2Blood Loss, Surgical 2Wrist Fractures 1Urologic Diseases 1Urinary Retention 1Thromboembolism 1Skin Neoplasms 1Seizures 1Sarcoma 1Recurrence 1Postoperative Complications 1Polyposis, Gastric 1Pituitary Neoplasms 1

Interventions

pembrolizumab 23Nivolumab 22aldesleukin 21Cyclophosphamide 20Ipilimumab 17Interleukin-2 17fludarabine 15fludarabine phosphate 14cemiplimab 12Radiotherapy 7Fluorouracil 7Dacarbazine 6binimetinib 5Vemurafenib 5Temozolomide 5Surgical Procedures, Operative 5Sirolimus 5Radiation 5Biopsy 5Aminolevulinic Acid 5encorafenib 4dabrafenib 4Photochemotherapy 4Educational Status 4trametinib 3sonidegib 3montanide ISA 51 3avelumab 3Tacrolimus 3Sodium Chloride 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Skin Neoplasms × Tranexamic Acid × Clear all
NCT04630886 2024-11-19

Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery

University of Massachusetts, Worcester

Phase EARLY_PHASE1 Terminated
34 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡